Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)

Conditions: Esophageal Cancer; Small Bowel Cancer; Gastroesophageal-junction Cancer; Gastric Cancer; Colorectal Cancer; Appendiceal Cancer; Biliary Cancer; Gall Bladder Cancer; Intrahepatic Cholangiocarcinoma; Extrahepatic Cholangiocarcinoma; Oligoprogressive Interventions: Device: Ablative local therapy Sponsors: University of California, Davis; National Cancer Institute (NCI) Recruiting

https://clinicaltrials.gov/study/NCT06101277

Source: ClinicalTrials.gov - October 26, 2023 Category: Research Source Type: clinical trials